Copy the page URI to the clipboard
Christiansen, Colette; Potier, Louis; Martin, Tiphaine C.; Villicaña, Sergio; Castillo-Fernandez, Juan E.; Mangino, Massimo; Menni, Cristina; Tsai, Pei-Chien; Campbell, Purdey J.; Mullin, Shelby; Ordoñana, Juan R.; Monteagudo, Olga; Sachdev, Perminder S.; Mather, Karen A.; Trollor, Julian N.; Pietilainen, Kirsi H.; Ollikainen, Miina; Dalgård, Christine; Kyvik, Kirsten; Christensen, Kaare; van Dongen, Jenny; Willemsen, Gonneke; Boomsma, Dorret I.; Magnusson, Patrik K. E.; Pedersen, Nancy L.; Wilson, Scott G.; Grundberg, Elin; Spector, Tim D. and Bell, Jordana T.
(2024).
DOI: https://doi.org/10.1016/j.ebiom.2024.105096
Abstract
Background
Type 2 diabetes (T2D) susceptibility is influenced by genetic and environmental factors. Previous findings suggest DNA methylation as a potential mechanism in T2D pathogenesis and progression.
Methods
We profiled DNA methylation in 248 blood samples from participants of European ancestry from 7 twin cohorts using a methylation sequencing platform targeting regulatory genomic regions encompassing 2,048,698 CpG sites.
Findings
We find and replicate 3 previously unreported T2D differentially methylated CpG positions (T2D-DMPs) at FDR 5% in RGL3, NGB and OTX2, and 20 signals at FDR 25%, of which 14 replicated. Integrating genetic variation and T2D-discordant monozygotic twin analyses, we identify both genetic-based and genetic-independent T2D-DMPs. The signals annotate to genes with established GWAS and EWAS links to T2D and its complications, including blood pressure (RGL3) and eye disease (OTX2).
Interpretation
The results help to improve our understanding of T2D disease pathogenesis and progression and may provide biomarkers for its complications.
Funding
Funding acknowledgements for each cohort can be found in the Supplementary Note.
CORE (COnnecting REpositories)
CORE (COnnecting REpositories)
